Latest Financial Instruments News

Almonty Industries has announced a $700 million convertible senior notes offering due 2031, aiming to refinance existing debt and fund corporate initiatives amid rising tungsten demand.

Xenitra Limited's OPAL Real World Asset tokenised sales ecosystem has generated over $500,000 in sales within its first month, onboarding more than 130 distributors and positioning the company as an early mover in blockchain-enabled FMCG sales in China.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) temporarily halted trading to relodge its FY25 Annual Report, revealing a $2.86 million loss driven by US market rationalisation and ongoing cost-cutting.

Celsius Resources has revealed it was not informed before Maharlika Investment Corporation assigned its loan under the Omnibus Loan and Security Agreement with Makilala Mining to an Indian firm, prompting legal and financial review.

Imricor Medical Systems updates its SEC Form 10 with minor SEC-driven revisions as it pushes forward with FDA clearances and clinical trials, reporting a $25.3 million net loss in 2025 amid early-stage commercialisation.

OM Holdings faced a challenging ferroalloy market in FY2025 but maintained production resilience, secured refinancing, and rationalised its portfolio through key asset sales, while advancing sustainability initiatives.

L1 Group has raised $950 million in the IPO of its L1 Gold Fund Limited, set to begin trading on the ASX on 24 April 2026. The fund targets gold and precious metals investments with significant founder and company backing.

Airtasker has secured a $5 million media partnership with Nine Entertainment, aiming to accelerate its brand growth across Australia’s leading media platforms. This strategic move comes as Airtasker rides strong marketplace momentum and positions itself for the evolving AI-driven labour market.

Excelsior Capital Limited reported a $2.08 million loss for the half-year ending December 2025 as it moves to wind up operations, yet declared a substantial fully franked interim dividend.

4DMedical Limited’s half-year report reveals rapid commercial traction following FDA clearance of its CT:VQ™ imaging technology, alongside a $150 million institutional placement that bolsters its cash reserves for global expansion.

Acusensus Limited reported a robust 40% increase in revenue to $40.3 million for the half-year ended December 2025, driven by new contracts and international growth. However, the company recorded a substantial $20.8 million loss, largely due to a $16 million litigation settlement and strategic investments in future growth.

Citigroup Global Markets Australia has announced the record and ex-dividend dates for a fully franked dividend on MFG ordinary shares and its linked CitiFirst Self-Funding Instalment MINI, with dividends directed to reduce outstanding loan amounts.